AMGEN INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.07 BRL | +0.40% |
|
+0.33% | +14.25% |
| 05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
| 05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
Quotes 5-day view
Delayed Quote Sao Paulo| 28/05/2024 | 29/05/2024 | 31/05/2024 | 03/06/2024 | |
|---|---|---|---|---|
| Last | 55.07 R$ | 55.25 R$ | 56.84 R$ | 57.07 R$ |
| Volume | 711 | 2 323 | 2 | 3 017 |
| Change | +∞% | +0.33% | +2.88% | +0.40% |
| Opening | 55.56 | 55.07 | 57.06 | 57.60 |
| High | 55.56 | 55.50 | 57.06 | 57.78 |
| Low | 55.07 | 55.07 | 56.84 | 56.84 |
Performance
| 1 day | +0.40% | ||
| 1 week | +0.33% | ||
| Current month | +0.40% | ||
| 1 month | +1.46% | ||
| 3 months | +15.15% | ||
| 6 months | +21.66% | ||
| Current year | +14.25% | ||
| 1 year | +51.74% | ||
| 3 years | +34.28% | ||
| 5 years | +137.43% | ||
| 10 years | +529.12% |
Volumes
marketsDaily volume
3 017
Estimated daily volume
11 496
Avg. Volume 20 sessions
316
Daily volume ratio
36.38
Avg. Volume 20 sessions BRL
18 034.12
Avg. Volume 20 sessions USD
3 436.83
Record volume 1
1 212 335
Record volume 2
1 083 599
Record volume 3
364 518
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (BRL)
164 910 753 014
Capitalization (USD)
164 910 753 014
Net sales (USD)
28 190 000 000
Number of employees
26 700
Sales / Employee (USD)
1 055 805
Free-Float
99.75 %
Free-Float capitalization (BRL)
31 318 318 622
Free-Float capitalization (USD)
164 502 600 395
Average Daily Capital Traded
0%
Highs and lows
1 week
55.07
57.78
1 month
54.0458.06
Current year
47.8558.36
1 year
37.5258.36
3 years
37.5258.36
5 years
23.4258.36
10 years
9.2658.36
Indicators
Moving average 5 days
56.06
Moving average 20 days
55.21
Moving average 50 days
51.61
Moving average 100 days
52.29
Price spread / (MMA5)
-1.77%
Price spread / (MMA20)
-3.26%
Price spread / (MMA50)
-9.57%
Price spread / (MMA100)
-8.38%
STIM
RSI 9 days
60.29
RSI 14 days
61.25
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.40% | +0.33% | +14.25% | +51.74% | 165B | ||
| -0.20% | +2.71% | +42.34% | +86.77% | 748B | ||
| +1.33% | +2.23% | +34.09% | +66.33% | 598B | ||
| -0.53% | +1.80% | -6.23% | -7.17% | 356B | ||
| +0.26% | +1.92% | +17.88% | +13.62% | 325B | ||
| +0.98% | +4.19% | +4.44% | +18.26% | 283B | ||
| +0.54% | +3.03% | +16.91% | +5.07% | 245B | ||
| -0.17% | +1.42% | +8.87% | +2.24% | 211B | ||
| +0.93% | +2.40% | -4.17% | -19.61% | 209B | ||
| +0.07% | +4.03% | +2.26% | -23.83% | 166B | ||
| +0.42% | +2.22% | +0.88% | -5.01% | 123B | ||
| +0.11% | +3.15% | -18.60% | -36.70% | 84.67B | ||
| +1.14% | -7.36% | +11.16% | +16.64% | 83.35B | ||
| +0.93% | +0.14% | -20.96% | -17.61% | 79.02B | ||
| -0.29% | -1.13% | +40.32% | +12.98% | 66.72B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +0.39% | -0.34% | +9.56% | +10.91% | ||
| Weighted average by Cap. | +0.39% | +0.66% | +17.45% | +29.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +14.25% | ||
| 2023 | -0.89% | ||
| 2022 | +11.16% | ||
| 2021 | +7.03% | ||
| 2020 | +20.00% | ||
| 2019 | +37.04% | ||
| 2018 | +23.77% | ||
| 2017 | +21.31% | ||
| 2016 | -23.03% | ||
| 2015 | +45.00% | ||
| 2014 | +58.51% | ||
| 2013 | +52.45% | ||
| 2012 | +5.11% |
- Stock Market
- Equities
- AMGN Stock
- AMGN34 Stock
- Quotes Amgen Inc.
